Cellectis Company
Cellectis is a biopharmaceutical company that develops adoptive immunotherapies for cancer.
Technology:
CAR-T
Industry:
CAR-T, Public
Headquarters:
Paris, Ile-de-France, France
Founded Date:
1999-12-01
Employees Number:
251-500
Funding Status:
IPO
Acquisitions Number:
2
Investors Number:
6
Total Funding:
248217750
Estimated Revenue:
$1M to $10M
Last Funding Date:
2023-02-07
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership